Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

Details for Australian Patent Application No. 2010282361 (hide)

Owner Acceleron Pharma Inc.

Inventors Seehra, Jasbir; Pearsall, Robert Scott; Kumar, Ravindra

Agent Shelston IP

Pub. Number AU-A-2010282361

PCT Pub. Number WO2011/020045

Priority PCT/ US2009/004659 13.08.09 US; 12/583,177 13.08.09 US; 61/305,901 18.02.10 US

Filing date 13 August 2010

Wipo publication date 17 February 2011

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

15 March 2012 PCT application entered the National Phase

  PCT publication WO2011/020045 Priority application(s): WO2011/020045

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282380-Spinning die assembly and method for forming fibres using said assembly

2010282359-Event-triggered server-side macros